Granules Pharmaceuticals successfully completes USFDA post marketing adverse drug experience inspection with zero observations
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
This product will be launched through Granules Consumer Health (GCH) division
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Metoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure.
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
The facility is over 79,000 square feet and is equipped with packaging lines
Losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure.
Granules now have a total of 53 ANDA approvals from USFDA
Subscribe To Our Newsletter & Stay Updated